Association of Disease-Modifying Treatment and Anti-CD20 Infusion Timing With Humoral Response to 2 SARS-CoV-2 Vaccines in Patients With Multiple Sclerosis.
JAMA Neurol
; 78(12): 1529-1531, 2021 12 01.
Article
in English
| MEDLINE | ID: covidwho-1432342
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antigens, CD20
/
Immunity, Humoral
/
COVID-19 Vaccines
/
COVID-19
/
Antibodies, Monoclonal
/
Multiple Sclerosis
Topics:
Vaccines
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
JAMA Neurol
Year:
2021
Document Type:
Article
Affiliation country:
Jamaneurol.2021.3609
Similar
MEDLINE
...
LILACS
LIS